On the 30th of March, Orbimed Advisors added 423 thousand Ikena Oncology, Inc. (IKNA) shares for $6.8 million at an average price of $16.00 per share.
Shares of Ikena Oncology, Inc. are down -3.83% since the transaction.
Orbimed Advisors’s holding in Ikena Oncology, Inc. increased to about 117 thousand shares with the purchase.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.